Trial intelligence / Profile preview

Cyclosporine in Hepatitis C Viral Clearance Following Liver Transplantation

NCT00821587Phase 4Completed

Sponsor
University of Florida
Start
Jun 2004
Primary completion
May 2008
Modality
Peptides, Small Molecules
01

Overview

A Phase 4 trial of cyclosporine in hepatitis C (HCV), sponsored by University of Florida. Started Jun 2004; status: completed.

02

Drugs

cyclosporine
03

Conditions

hepatitis C (HCV)

Beyond the preview

Go deeper on NCT00821587.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00821587.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call